Published in Nutr J on January 13, 2012
Traditional Indian medicines used for the management of diabetes mellitus. J Diabetes Res (2013) 0.96
Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes. Int J Environ Res Public Health (2014) 0.88
Cucurbitane Triterpenoid from Momordica charantia Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-Activated Receptor γ Activation. Evid Based Complement Alternat Med (2013) 0.83
Novel nutraceutic therapies for the treatment of metabolic syndrome. World J Diabetes (2016) 0.79
Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome. J Lipids (2015) 0.76
Overview of Botanical Status in EU, USA, and Thailand. Evid Based Complement Alternat Med (2013) 0.76
Role of GLP-1 in the Hypoglycemic Effects of Wild Bitter Gourd. Evid Based Complement Alternat Med (2013) 0.76
Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy. Semin Cancer Biol (2016) 0.75
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care (2004) 3.87
Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care (2010) 3.37
PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci (2005) 2.90
Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr (2007) 2.86
Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care (2003) 2.75
C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists. Mol Cell Biol (2009) 1.98
Traditional chinese medicine in treatment of metabolic syndrome. Endocr Metab Immune Disord Drug Targets (2008) 1.94
Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol (2004) 1.89
Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol (1998) 1.70
Bitter melon (Momordica charantia): a review of efficacy and safety. Am J Health Syst Pharm (2003) 1.70
Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease. South Med J (2008) 1.55
Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol (2008) 1.45
Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats. J Ethnopharmacol (2009) 1.23
Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol (1986) 1.15
Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia. Nutr Rev (2006) 1.11
Hypoglycemic activity of polypeptide-p from a plant source. J Nat Prod (1982) 1.11
Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets. J Ethnopharmacol (2000) 1.07
Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet. Diabetes Res Clin Pract (2008) 1.05
Ironic effects of dietary supplementation: illusory invulnerability created by taking dietary supplements licenses health-risk behaviors. Psychol Sci (2011) 1.03
Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells. J Biomed Sci (2003) 1.01
Application of modified in vitro screening procedure for identifying herbals possessing sulfonylurea-like activity. J Ethnopharmacol (2004) 0.99
Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin Pharmacol Toxicol (2005) 0.97
Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice. J Nutr Biochem (2011) 0.96
Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARalpha in bitter gourd (Momordica charantia L.). J Biomed Sci (2006) 0.92
Fruit extracts of Momordica charantia potentiate glucose uptake and up-regulate Glut-4, PPAR gamma and PI3K. J Ethnopharmacol (2009) 0.90
Alpha-glucosidase inhibitor from the seeds of balsam pear (Momordica charantia) and the fruit bodies of Grifola frondosa. Biosci Biotechnol Biochem (2002) 0.89
Momordica charantia for type 2 diabetes mellitus. Cochrane Database Syst Rev (2010) 0.88
alpha-Glucosidase inhibition properties of cucurbitane-type triterpene glycosides from the fruits of Momordica charantia. Chem Pharm Bull (Tokyo) (2010) 0.88
Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity. Can J Appl Physiol (2004) 0.88
Cucurbitane-type triterpenoids from Momordica charantia. Planta Med (2010) 0.85
Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment. Phytomedicine (2009) 0.83
Critical role of peroxisome proliferator activated receptor-δ on body fat reduction in C57BL/6J and human apolipoprotein E2 transgenic mice fed delipidated soybean. J Agric Food Chem (2011) 0.80
"Karella" in the treatment of diabetes mellitus. Indian J Med Sci (1968) 0.80
Activating effect of momordin, extract of bitter melon (Momordica Charantia L.), on the promoter of human PPARdelta. J Atheroscler Thromb (2009) 0.78
Anticancer effects of tanshinone I in human non-small cell lung cancer. Mol Cancer Ther (2008) 1.20
Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells. J Biomed Sci (2003) 1.01
Hyperhydricity in shoot cultures of Scrophularia yoshimurae can be effectively reduced by ventilation of culture vessels. J Plant Physiol (2005) 1.00
Factor analysis of modifiable cardiovascular risk factors and prevalence of metabolic syndrome in adult Taiwanese. Endocrine (2011) 0.92
Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARalpha in bitter gourd (Momordica charantia L.). J Biomed Sci (2006) 0.92
Withanolide sulfoxide from Aswagandha roots inhibits nuclear transcription factor-kappa-B, cyclooxygenase and tumor cell proliferation. Phytother Res (2009) 0.90
Bioactivity-guided screening identifies pheophytin a as a potent anti-hepatitis C virus compound from Lonicera hypoglauca Miq. Biochem Biophys Res Commun (2009) 0.90
Profiling and characterization antioxidant activities in Anoectochilus formosanus hayata. J Agric Food Chem (2002) 0.88
Lonicera hypoglauca inhibits xanthine oxidase and reduces serum uric acid in mice. Planta Med (2009) 0.87
The hepatoprotective activity of kinsenoside from Anoectochilus formosanus. Phytother Res (2007) 0.84
Metabolite identification for mass spectrometry-based metabolomics using multiple types of correlated ion information. Anal Chem (2015) 0.83
Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia. J Agric Food Chem (2011) 0.83
Micropropagation of Polygonum multiflorum THUNB and quantitative analysis of the anthraquinones emodin and physcion formed in in vitro propagated shoots and plants. Biol Pharm Bull (2003) 0.83
Improving effects of epigallocatechin-3-gallate on hemorheological abnormalities of aging Guinea pigs. Circ J (2007) 0.81
Phytoestrogenic compounds in alfalfa sprout (Medicago sativa) beyond coumestrol. J Agric Food Chem (2010) 0.81
Bioguided fractionation and isolation of free radical scavenging components from in vitro propagated chinese medicinal plants Dendrobium tosaense Makino and Dendrobium moniliforme SW. J Agric Food Chem (2004) 0.81
In vitro propagation by asymbiotic seed germination and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity studies of tissue culture raised plants of three medicinally important species of dendrobium. Biol Pharm Bull (2004) 0.80
Two novel vitamin D receptor modulators with similar structures exhibit different hypercalcemic effects in 5/6 nephrectomized uremic rats. Am J Nephrol (2013) 0.80
Isolation and identification of alpha-CEHC sulfate in rat urine and an improved method for the determination of conjugated alpha-CEHC. J Agric Food Chem (2008) 0.80
Changes in liver PPARalpha mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice. J Nutr Biochem (2006) 0.80
Improving abnormal hemorheological parameters in aging guinea pigs by water-soluble extracts of Salvia miltiorrhiza Bunge. J Ethnopharmacol (2006) 0.78
Isolation and quantitative analysis of cryptotanshinone, an active quinoid diterpene formed in callus of Salvia miltiorrhiza BUNGE. Biol Pharm Bull (2003) 0.77
T-DNA activation tagging as a tool to isolate Salvia miltiorrhiza transgenic lines for higher yields of tanshinones. Planta Med (2008) 0.76
Development of an activation tagging system for the basidiomycetous medicinal fungus Antrodia cinnamomea. Mycol Res (2008) 0.76
Anti-metastatic activity of biologically synthesized gold nanoparticles on human fibrosarcoma cell line HT-1080. Colloids Surf B Biointerfaces (2013) 0.75
A Food in Health Security (FIHS) platform in the Asia-Pacific Region: the way forward. Asia Pac J Clin Nutr (2009) 0.75
Plasma retinol and a-tocopherol status of the Taiwanese elderly population. Asia Pac J Clin Nutr (2005) 0.75
The opportunities and challenges of evidence-based nutrition (EBN) in the Asia Pacific region: clinical practice and policy-setting. Asia Pac J Clin Nutr (2008) 0.75